Medscape2m
Is One Cycle of Neoadjuvant Pembro Enough in dMMR Colon Cancer?
About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.
I'm a colorectal cancer survivor and advocate. Here are 5 things you should and shouldn't do
Barry Stein had ignored symptoms that started appearing in 1995, until he was diagnosed with stage four colorectal cancer.
New study uncovers the biggest risk factor for colon cancer in under 35s — and it will shock you
A diet deficient in calcium was considered the highest risk factor, linked to approximately one in five deaths from colon ...
In HER2+ colorectal cancer, anti-HER2 therapy may be less toxic alternative
Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...
Rolling Out7d
5 symptoms of colon cancer that require immediate attention
Colon cancer remains one of the most prevalent yet often undetected forms of cancer, developing silently in the large ...
5 signs of colorectal cancer you should never ignore — including one you might be happy about
About 150,000 Americans are diagnosed annually with colorectal cancer, which occurs when cells in the colon or rectum grow ...
earth1d
Medicinal plant has great potential to fight colorectal cancer
Artemisia herba-alba shows promise in combating colorectal cancer, offering new hope through its powerful medicinal ...
StudyFinds on MSN2d
Desert plant shows promise as colorectal cancer treatment
In a nutshell A common desert plant called Artemisia herba-alba contains compounds that can effectively kill colorectal ...
Daily Aspirin Reduces Colon Cancer Risk: Study
Taking 160 milligrams of aspirin a day cuts the risk of cancer recurrence in half among colon cancer patients with a mutation in their PI3K genes, researchers reported at the 2025 American Society of ...
Groundbreaking Bowel Cancer Test Is 90 Percent Accurate At Predicting Disease In Those At High Risk
Scientists say a groundbreaking new test can predict patients at high risk of developing bowel cancer with 90 per cent ...